Home › Funds › SurgoCap Partners LP › CRS
SurgoCap Partners LP position in CRS
CARPENTER TECHNOLOGY CORPORATION · Industrials
SurgoCap Partners LP reported holding 686,473 shares of CRS (CARPENTER TECHNOLOGY CORPORATION) in its Q2 2026 13F filing — a position valued at US$423.4M, representing 13.69% of its reported portfolio and ranking #2 among its reported holdings. SurgoCap Partners LP has disclosed CRS holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SurgoCap Partners LP's CRS position evolved
SurgoCap Partners LP first disclosed a stake in CRS in Q3 2024 at 662,712 shares (US$105.8M). The position peaked in Q1 2026 at 1,196,901 shares, worth US$471.8M. Across 8 filings, SurgoCap Partners LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 686,473 shares valued at US$423.4M — a reduction of -510,428 shares quarter over quarter.. Notable position changes include a 118% increase in Q4 2024 (shares rose 7% over the following quarter), a 43% trim in Q2 2025 (shares fell 11% over the following quarter), a 43% trim in Q2 2026 (shares fell 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 662.71K | $105.76M | New |
| Q4 2024 | 1.44M | $244.73M | Add |
| Q1 2025 | 1.61M | $292.06M | Add |
| Q2 2025 | 926.00K | $255.93M | Reduce |
| Q3 2025 | 1.20M | $294.38M | Add |
| Q4 2025 | 1.15M | $362.89M | Reduce |
| Q1 2026 | 1.20M | $471.76M | Add |
| Q2 2026 | 686.47K | $423.44M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRS and 13F data
CRS (CARPENTER TECHNOLOGY CORPORATION) is a Industrials company. 63 other funds we track also report a position in CRS — the largest reported positions include AQR Capital Management (US$900.2M), AQR CAPITAL MANAGEMENT LLC (US$900.2M), JENNISON ASSOCIATES LLC (US$735.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRS
- AQR Capital Management 1.46M sh · $900.23M · Q2 2026
- AQR CAPITAL MANAGEMENT LLC 1.46M sh · $900.23M · Q2 2026
- JENNISON ASSOCIATES LLC 1.19M sh · $735.70M · Q2 2026
- Lone Pine Capital 962.84K sh · $593.92M · Q2 2026
- LONE PINE CAPITAL LLC 962.84K sh · $593.92M · Q2 2026
- SANDS CAPITAL MANAGEMENT, LLC 786.15K sh · $484.93M · Q2 2026
- LORD, ABBETT & CO. LLC 439.60K sh · $271.16M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 332.61K sh · $205.17M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 314.08K sh · $193.74M · Q2 2026
- TimesSquare Capital Management, LLC 291.62K sh · $179.88M · Q2 2026
- Qube Research & Technologies Ltd 287.76K sh · $177.50M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 227.20K sh · $140.15M · Q2 2026
More on SurgoCap Partners LP
FAQ
How long has SurgoCap Partners LP held CRS?
SurgoCap Partners LP has disclosed CRS holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is SurgoCap Partners LP's current position in CRS?
As of Q2 2026, SurgoCap Partners LP holds 686.47K shares of CRS (CARPENTER TECHNOLOGY CORPORATION), valued at $423.44M, representing 13.69% of its reported portfolio and ranking #2.
Has SurgoCap Partners LP been buying or selling CRS?
In the latest 13F filing (Q2 2026), SurgoCap Partners LP reduced its position in CRS. The position peaked in Q1 2026 at 1.20M shares.
Which other funds hold CRS?
Other major institutional holders of CRS include AQR Capital Management, AQR CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, among 63 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.